You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR TEMOVATE E


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for TEMOVATE E

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00297011 ↗ Valacyclovir+Temovate Gel for the Treatment of Herpes Labialis Completed GlaxoSmithKline Phase 2 2004-09-01 A randomized study comparing the combination of valacyclovir and temovate gel (clobetasol gel) versus placebo for the treatment of recurrent herpes labialis (cold sores).
NCT00297011 ↗ Valacyclovir+Temovate Gel for the Treatment of Herpes Labialis Completed University of Utah Phase 2 2004-09-01 A randomized study comparing the combination of valacyclovir and temovate gel (clobetasol gel) versus placebo for the treatment of recurrent herpes labialis (cold sores).
NCT00470392 ↗ Mechanistically-based Optimization of UV Radiation Therapy in Psoriasis Terminated University Hospitals Cleveland Medical Center N/A 2007-05-01 The purpose of this study is 1) to determine whether Imiquimod or Steroid pretreatment modifies UVB laser light response resulting in increased cell death compared to UVB laser light alone; 2) to determine if pretreatment of psoriatic lesions with Imiquimod or Steroid prior to UVB laser light exposure selectively effects various T cell functions; 3) to determine clinical results from the Imiquimod/Steroid/UVB laser light and correlate those changes with immuno-histochemical changes in the skin; and 4) to determine if single high dose lesion limited UVB laser light intervention combined with Imiquimod or Steroid influences T cell changes
NCT00470392 ↗ Mechanistically-based Optimization of UV Radiation Therapy in Psoriasis Terminated VA Office of Research and Development N/A 2007-05-01 The purpose of this study is 1) to determine whether Imiquimod or Steroid pretreatment modifies UVB laser light response resulting in increased cell death compared to UVB laser light alone; 2) to determine if pretreatment of psoriatic lesions with Imiquimod or Steroid prior to UVB laser light exposure selectively effects various T cell functions; 3) to determine clinical results from the Imiquimod/Steroid/UVB laser light and correlate those changes with immuno-histochemical changes in the skin; and 4) to determine if single high dose lesion limited UVB laser light intervention combined with Imiquimod or Steroid influences T cell changes
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for TEMOVATE E

Condition Name

Condition Name for TEMOVATE E
Intervention Trials
Herpes Labialis 1
Psoriasis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for TEMOVATE E
Intervention Trials
Psoriasis 1
Herpes Labialis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for TEMOVATE E

Trials by Country

Trials by Country for TEMOVATE E
Location Trials
United States 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for TEMOVATE E
Location Trials
Ohio 1
Utah 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for TEMOVATE E

Clinical Trial Phase

Clinical Trial Phase for TEMOVATE E
Clinical Trial Phase Trials
Phase 2 1
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for TEMOVATE E
Clinical Trial Phase Trials
Completed 1
Terminated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for TEMOVATE E

Sponsor Name

Sponsor Name for TEMOVATE E
Sponsor Trials
VA Office of Research and Development 1
GlaxoSmithKline 1
University of Utah 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for TEMOVATE E
Sponsor Trials
Other 2
U.S. Fed 1
Industry 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.